Effect of spironolactone on testosterone and LHRH responsiveness in women with polycystic ovarian disease.
D000328:Adult; D004958:Estradiol / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D007987:Gonadotropin-Releasing Hormone / Q000097:blood*; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D010060:Ovulation / Q000187:drug effects; D011085:Polycystic Ovary Syndrome / Q000188:drug therapy*; D011388:Prolactin / Q000097:blood; D011863:Radioimmunoassay; D013148:Spironolactone / Q000494:pharmacology / Q000627:therapeutic use*; D013739:Testosterone / Q000097:blood*
D013148:Spironolactone; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D004958:Estradiol; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone